As shown in table 4, ALT level in patients with NAFLD was significantly higher than control group in all three genotypes (p=0.022); meanwhile AST level was higher in GT and GG genotypes in NAFLD group as compared to control (p<0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.